Evaluation of the Pathobiology of CALR-mutated MPN Cells

Evaluation of the Pathobiology of CALR-mutated MPN Cells
Conditions: Myeloproliferative Neoplasm

Interventions: Other: Blood Draw

Sponsors: Wake Forest University Health Sciences; Atrium Health Levine Cancer Institute; Brookdale University Hospital Medical Center

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 29, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments